Diabetes mellitus

Related records

Broader conditions (10)

• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Endocrine pancreas disorder
• Endocrine system disorder
• Glucose metabolism disease
• Human disease
• Metabolic disease
• Pancreas disorder

Narrower conditions (48)

• Cystic fibrosis-related diabetes
• DEND syndrome
• Developmental delay, epilepsy, and neonatal diabetes 1
• Developmental delay, epilepsy, and neonatal diabetes 2
• Diabetes mellitus, noninsulin-dependent, 1
• Diabetes mellitus, noninsulin-dependent, 2
• Diabetes mellitus, noninsulin-dependent, 3
• Diabetes mellitus, noninsulin-dependent, 4
• Diabetes mellitus, noninsulin-dependent, 5
• Diabetes mellitus, permanent neonatal 2
• Diabetes mellitus, permanent neonatal 3
• Diabetes mellitus, permanent neonatal 4
• Diabetes mellitus, transient neonatal, 1
• Diabetes mellitus, transient neonatal, 2
• Diabetes mellitus, transient neonatal, 3
• Diabetic ketoacidosis
• EIF2B1-related permanent neonatal diabetes with transient liver dysfunction
• Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young
• Gestational diabetes
• Intermediate DEND syndrome

Trials (8,426)

• "Assessing Barriers to ADA Guideline Adherence"
• "COVID-19 and Diabetes Outcomes"
• "Erectile Function After PCI in MI and Non-MI Patients"
• "F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)
• "Fit For Kids"-Copenhagen
• "Health in Mobile" for Community-dwelling Individuals With Chronic Diseases
• "ISIS" Study of Sex Differences in Characteristics of Adiposity and Metabolism
• "Outcome of Diabetes Education Among Renal Transplant Recipients With New Onset Diabetes After Transplantation (NODAT)"
• "POWER2DM Evaluation Campaign"
• "Shoulder Musculoskeletal Disorders in Type 2 Diabetes Mellitus: Contributing Factors and Rehabilitation Protocol"
• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients
• "Working for You" Workplace Obesity Intervention
• 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients
• 1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin Ratio as a Potential Biomarker for Islet β-cell Function and Insulin Resistance Among Patients With Type 2 Diabetes Mellitus
• 10 Years Follow-up Study of Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes
• 10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong
• 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
• 15-minute Individual Consultation to Improve Blood Glucose Control in Pre-diabetes
• 2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides

Approved drugs (78)

• Acarbose
• Acetohexamide
• Albiglutide
• Amlodipine besylate
• Atenolol
• Benazepril hydrochloride
• Benfluorex
• Bexagliflozin
• Buformin
• Canagliflozin
• Candesartan cilexetil
• Chlorpropamide
• Dapagliflozin
• Dasiglucagon hydrochloride
• Dulaglutide
• Duloxetine hydrochloride
• Empagliflozin
• Evogliptin
• Exenatide
• Felodipine

Drugs in development (152)

• Acetaminophen Phase 1
• Albuterol Phase 1
• Aldafermin Phase 2
• Alirocumab Phase 3
• Aliskiren Phase 3
• Allopurinol Phase 2
• Alogliptin Phase 3
• AMG-108 Phase 2
• Amitriptyline Phase 2
• Amlodipine Phase 3
• Anakinra Phase 2
• Apabetalone Phase 2
• Apelin Phase 1
• Ascorbic acid Phase 3
• Aspirin Phase 3
• Atorvastatin Phase 3
• ATX08-001 Phase 2
• Azilsartan Phase 2
• Benazepril Phase 3
• Berberine chloride Early phase 1

Other linked drugs (13)

• Alogliptin benzoate
• Alprostadil
• Aspartic acid
• Becaplermin
• Colesevelam hydrochloride
• Dexmedetomidine
• Domperidone
• GLP-1
• Lidocaine
• Omega-3 fatty acids
• Prednisolone
• Sodium phenylbutyrate
• Ticagrelor